Sotera Health Company
soterahealth.comWhat Do They Do?
Provides sterilization and irradiation, lab testing and advisory services to healthcare, food and industrial companies. Sells radioactive cobalt sources and gamma irradiation systems to contract sterilizers and medical-device makers.
10-K for FY2025, filed Feb 24, 2026We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the…View ↗
We are a leading global provider of outsourced terminal sterilization and irradiation services and have provided sterilization services for…View ↗
We offer our customers a complete range of terminal sterilization services, primarily using the three major commercial terminal…View ↗
Sterigenics primarily provides sterilization services for medical device manufacturers and the pharmaceutical industry and also provides…View ↗
Nordion is the leading global provider of Co-60 used in sterilization and irradiation processes for the medical device, pharmaceutical…View ↗
We also design, install and maintain gamma irradiation systems, which include radiation shielding, a series of conveyors and control…View ↗
How Do They Make Money?
Customers pay for Sterigenics sterilization when processing is complete and quality-approved; lab services are earned over time. Nordion sells cobalt sources on delivery and earns service revenue from installation, disposal and gamma-system work.
10-K for FY2025, filed Feb 24, 2026Service revenues primarily consist of revenue generated from contract sterilization and lab testing and advisory services within our…View ↗
Our Sterigenics segment provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food…View ↗
Our Nordion segment is a global provider of Co-60 and gamma irradiation systems, which are key components to the gamma sterilization…View ↗
Year Ended December 31, 2025 Sterigenics Nordion Nelson Labs Consolidated Point in time $ 755,780 $ 182,822 $ — $ 938,602 Over time — 4,796…View ↗
-
10-K for FY2025, filed Feb 24, 2026
FY2025 revenue by product or service ↗
$1.2B
-
10-K for FY2025, filed Feb 24, 2026
$1.2B ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Service
Sold outright
10-K for FY2025, filed Feb 24, 2026 |
86%
FY2022: 86%
|
Service, FY2025
$995.8M Sources
|
Sold outright |
|
Product
Sold outright
10-K for FY2025, filed Feb 24, 2026 |
14%
FY2022: 14%
|
Product, FY2025
$167.9M Sources
|
Sold outright |
Who Are Their Customers?
Sterigenics serves medical-device and pharmaceutical makers, food and agricultural producers, and industrial users; Nordion serves contract sterilizers and medical-device manufacturers. Nelson Labs provides testing and advisory services for healthcare customers.
10-K for FY2025, filed Feb 24, 2026Sterigenics primarily provides sterilization services for medical device manufacturers and the pharmaceutical industry and also provides…View ↗
Sterigenics serves more than 2,000 customers in industries ranging from medical device and healthcare products, pharmaceuticals, food and…View ↗
Nordion primarily serves medical device manufacturers and gamma sterilization service providers. We are integral to our customers’…View ↗
We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 7 cents of every revenue dollar as net income in FY2025 and turned 13 cents into free cash flow.
10-K for FY2025, filed Feb 24, 2026
$392.8MView ↗
10-K for FY2025, filed Feb 24, 2026
$77.9MView ↗
10-K for FY2025, filed Feb 24, 2026
$149.2MView ↗
How Are They Changing?
10-Q for Q2 FY2026, filed Aug 6, 2026
Open tableView ↗
-
Aug 6, 2026
Raised full-year revenue and adjusted EBITDA outlook
Raised its revenue growth outlook to 5.25% to 6.75% and adjusted EBITDA growth outlook to 5.75% to 7.25%.
Sources
8-K, filed Aug 6, 2026
Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis(1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19…View ↗
-
May 5, 2026
Alton Shader became CEO as Michael Petras moved to executive chairman
Sources
8-K, filed May 5, 2026
In accordance with the Company’s executive succession plans, on May 5, 2026, the Company announced a leadership transition pursuant to…View ↗
Growing. Revenue grew 25% in 4 years, from $931.5M in FY2021 to $1.2B in FY2025, about 6% a year.
Who Do They Compete With?
Competes with STERIS
10-K for FY2025, filed Feb 24, 2026We compete globally with Applied Sterilization Technologies, a segment of STERIS plc, as well as other smaller or regional outsourced…View ↗
Loading...
